Abstract
Cardiovascular disease is one of the leading causes of morbidity and mortality around the world. Even after successful revascularization in coronary artery disease, cell death continues and the loss of cardiomyocytes eventually leads to progressive ventricular dilation and heart dysfunction. The notion of repairing or regenerating lost myocardium via cell-based therapies remains highly appealing. The recent identification of human stem cells, including embryonic stem cells and adult stem cells, has raised optimism for the development of a new therapy. This new cell-therapy and the concept of regenerative medicine is aimed at restoring the damaged myocardium, both vasculature and muscle. Here, we review the stem cell field and other available cell sources for myocardial regeneration, focusing on the up-to-date status of stem cell biology, recent laboratory advances and the current clinical applications. In addition, the limitations and practical hurdles that need urgent solution before more extensive applications become feasible are also discussed.
Keywords: Myocardial regeneration, stem cells, differentiation, cardiomyocytes
Current Molecular Medicine
Title: Cell Therapy for Myocardial Regeneration
Volume: 9 Issue: 3
Author(s): Jia Liu, Joost P.G. Sluijter, Marie-Jose Goumans, Anke M. Smits, Tycho van der Spoel, Hendrik Nathoe and Pieter A. Doevendans
Affiliation:
Keywords: Myocardial regeneration, stem cells, differentiation, cardiomyocytes
Abstract: Cardiovascular disease is one of the leading causes of morbidity and mortality around the world. Even after successful revascularization in coronary artery disease, cell death continues and the loss of cardiomyocytes eventually leads to progressive ventricular dilation and heart dysfunction. The notion of repairing or regenerating lost myocardium via cell-based therapies remains highly appealing. The recent identification of human stem cells, including embryonic stem cells and adult stem cells, has raised optimism for the development of a new therapy. This new cell-therapy and the concept of regenerative medicine is aimed at restoring the damaged myocardium, both vasculature and muscle. Here, we review the stem cell field and other available cell sources for myocardial regeneration, focusing on the up-to-date status of stem cell biology, recent laboratory advances and the current clinical applications. In addition, the limitations and practical hurdles that need urgent solution before more extensive applications become feasible are also discussed.
Export Options
About this article
Cite this article as:
Liu Jia, Sluijter P.G. Joost, Goumans Marie-Jose, Smits M. Anke, Spoel van der Tycho, Nathoe Hendrik and Doevendans A. Pieter, Cell Therapy for Myocardial Regeneration, Current Molecular Medicine 2009; 9 (3) . https://dx.doi.org/10.2174/156652409787847218
DOI https://dx.doi.org/10.2174/156652409787847218 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Altered Calcium Handling in Reperfusion Injury
Medicinal Chemistry Epicardial and Intramyocardial Adipose Tissue: The Enemy within
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Recent Advances in the Development of MMPIs and APNIs Based on the Pyrrolidine Platforms
Mini-Reviews in Medicinal Chemistry Imaging of Visceral Adipose Tissue: An Emerging Diagnostic Tool and Therapeutic Target
Current Drug Targets - Cardiovascular & Hematological Disorders Molecular Genetics of Left Ventricular Dysfunction
Current Molecular Medicine Oxidative-Nitrosative Stress as a Contributing Factor to Cardiovascular Disease in Subjects with Diabetes
Current Vascular Pharmacology Mitochondrial, Metabolic and Genotoxic Effects of Antiretroviral Nucleoside Reverse-Transcriptase Inhibitors
Anti-Infective Agents in Medicinal Chemistry Developments in Imaging Technologies Related to Hypertensive Cardiovascular Diseases
Current Pharmaceutical Design Atrial Natriuretic Peptide: Structure, Function, and Physiological Effects: A Narrative Review
Current Cardiology Reviews Rational Targeting of Peroxisome Proliferating Activated Receptor Subtypes
Current Medicinal Chemistry The Impact of Small Heat Shock Proteins (HspBs) in Alzheimer’s and Other Neurological Diseases
Current Pharmaceutical Design Regulatable Gene Expression Systems for Gene Therapy
Current Gene Therapy Plasma Glucose Concentrations and Cardiac Hypertrophy in Essential Hypertension
Current Hypertension Reviews Cardiac Workup of Ischemic Stroke
Current Cardiology Reviews Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function?
Current Drug Targets S-nitrosation/Denitrosation in Cardiovascular Pathologies: Facts and Concepts for the Rational Design of S-nitrosothiols
Current Pharmaceutical Design Endothelin Signalling in the Cardiac Myocyte and its Pathophysiological Relevance
Current Vascular Pharmacology AMP-Activated Protein Kinase (AMPK): Regulation of Metabolic Gene Expression
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Therapeutic Intervention in Cancer and Chronic Viral Infections: Antibody Mediated Manipulation of PD-1/PD-L1 Interaction
Reviews on Recent Clinical Trials Cell Sheet-Based Myocardial Tissue Engineering: New Hope for Damaged Heart Rescue
Current Pharmaceutical Design